Shares of Adaptive Biotechnologies Corporation (NASDAQ:ADPT) traded at a new 52-week high today of $57.27. So far today approximately 122,000 shares have been exchanged, as compared to an average 30-day volume of 700,000 shares.
In the past 52 weeks, Adaptive Biotechnologies Corporation share prices are bracketed by a low of $15.19 and a high of $57.27 and is now at $55.70, 267% above that low price.
Potential upside of 73.6% exists for Adaptive Biotechnologies Corporation, based on a current level of $55.70 and analysts’ average consensus price target of $96.70.
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis…
Receive IBN Spotlights – “Bit Size” Small, Mid and Large-Cap Technical Indicator Alerts
To stay connected with our complimentary IBN alerts, please visit https://IBN.fm/connected
About InvestorBrandNetwork (IBN)
InvestorBrandNetwork (IBN) consists of 50+ trusted financial brands introduced to the investment public over the course of 15+ years. Through these brands, IBN provides (1) access to our Investor Press Release Wire Solutions via InvestorWire (IW) to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions via IW to ensure maximum impact; (4) full-scale distribution to an enormous social media audience that includes millions of followers; and (5) a full array of corporate communications solutions focused on the IBN Podcast Series. With a proven track record serving 500+ client partners, IBN is the key to a more effective market communication campaign.
For more information, please visit https://www.InvestorBrandNetwork.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer